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The National Institute of Environmental Health Sciences (NIEHS) has several new initiatives
involving chemical mixtures and has recognized the need to develop new experimental
approaches to enhance our efforts in this area. Responding to recent increases in nominations of
complex occupational exposures for toxicologic assessment by the U.S. National Toxicology
Program, the NIEHS and the National Institute for Occupational Safety and Health have begun a
program to characterize exposures through field studies, identify biomarkers of exposure in
workers, and recreate relevant mixed exposures in a laboratory setting. A second initiative with
the National Center for Environmental Health/Centers for Disease Control and Prevention will
examine blood samples from the U.S. National Health and Nutrition Examination Survey
population surveys for selected endocrine-disrupting agents and for common patterns of
persistent xenobiotics, providing critical information for the design of animal studies to assess
risks of relevant chemical mixtures to humans. New toxicology testing methods (lower cost,
faster) will enhance our ability to study chemical mixtures (e.g., dioxin and dioxinlike chemicals,
combination AIDS therapies). Ongoing method development efforts involve in vitro functional
toxicology assays, screens for estrogenic activity, and carcinogenesis studies in transgenic mice.
A major scientific initiative with mixtures involves studies of individual and mixtures of dioxin and
dioxinlike chemicals to determine if toxic equivalence factors predict carcinogenic potency in
traditional and transgenic bioassays. Complementing these studies is an increased emphasis on
physiologically based pharmacokinetic modeling, an activity central to the proper interpretation
of chemical mixture studies. Environ Health Perspect 106(Suppl 6):1295-1298 (1998).
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There are formidable intellectual challenges host ofother issues have tended to impede
associated with the study ofchemical mix- research progress in this area.
tures for potential adverse human health During the 1980s rather intense efforts
effects. These challenges range from the were made at the National Institute of
rather mundane problems associated with Environmental Health Sciences (NIEHS)
the creation of stable dose solutions or to provide data to address some ofthe fun-
aerosols ofchemical mixtures for delivery to damental knowledge gaps in studies of
animals or other test systems, to more diffi- chemical mixtures. These efforts were in
cult and serious problems associated with response to the recommendations of a
the selection ofmixtures for study that pro- committee assembled by the National
vide data relevant to more than one or two Research Council/National Academy of
unique exposure situations. These and a Sciences following its review oftoxicologic
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and epidemiologic data from studies of
well-characterized chemical mixtures (1,2).
The approach taken was to characterize the
toxicity of several well-defined complex
chemical mixtures, with plans for follow-up
studies to investigate, in depth, factors that
accounted for deviations from additivity in
toxic responses. Three complex mixtures
representing groundwater contamination
were chosen for study. Onewas a 25-chem-
ical mixture design based on the U.S.
Environmental Protection Agency (U.S.
EPA) groundwater contaminant survey
information; two other mixtures mimicked
pesticide and fertilizer contamination found
in California and Iowa (3,4). Although the
pesticide/fertilizer studies did not identify
toxic effects in experimental animals, there
were adverse health findings with the 25-
chemical mixture. Subsequent work on this
mixture examined the way in which coexpo-
sure to low doses ofthe chemical mixture
influenced the acute toxicity ofhigher doses
ofknown hepatic and renal toxicants (5).
More recently, the focus of chemical
mixture research at NIEHS has moved
away from broad toxicity screening studies
of contrived mixtures toward studies of
mixed exposures encountered in occupa-
tional or environmental settings, and
studies ofthe behavior ofsimpler mixtures
that may share common mechanisms of
action. Concurrently, new developments
in alternative test models are providing
promise that methods will soon be avail-
able that will allow us to carry out more
studies on selected relevant mixtures in
a more cost-effective manner. Some of
these new initiatives are described in the
following sections.
A new NIEHS/National Institute for
Occupational Safety and Health (NIOSH)
interagency agreement is supporting
research at NIOSH that specifically
addresses occupational exposures nomi-
nated for toxicological characterization to
the U.S. National Toxicology Program
(U.S. NTP). Such research will include
field studies and/or laboratory re-creation
of occupational exposure conditions to
determine relevant exposure characteristics
and levels, efforts to identify biomarkers of
exposure in workers and to evaluate such
biomarkers in animal models for use as a
cross-species dose metric, and short-term
inhalation laboratory studies to identify
appropriate exposure generation and
measurement approaches and determine
relevant responses to exposure.
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This interagency agreement may also
support short-term inhalation toxicokinetic
studies that may link results from chronic
rodent inhalation exposures to single agents
with exposures to those agents as complex
mixtures. An example ofthis would be an
examination of the relevance ofthe recent
findings ofcarcinogenicity in rodent studies
ofan inhaled water soluble cobalt salt (6)
to occupational exposures to cobalt as it
appears in differentwelding fumes or in the
hard metal cobalt alloy industry.
A second interagency agreement that
should be extremely helpful in guiding the
design ofmixture work in the years ahead is
under development with the National
Center for Environmental Health (NCEH),
Centers for Disease Control and Prevention.
The NCEH has laboratory and epidemio-
logic expertise in the measurement of the
extent of human exposures to toxic sub-
stances andworks to determine the levels of
exposure that cause human disease. As the
principal analytical laboratoryworking with
blood samples from large population-based
surveys such as National Health and
Nutrition Examination Surveys III and IV,
the NCEH has compiled information on
the frequency and concentration ranges of
many persistent organic chemicals and met-
als in the U.S. population. Future NIEHS-
sponsored activities will include an analysis
ofthe databases to determine whether there
are common subsets ofchemicals that per-
sist in large segments of the population.
These subsets, ifthey exist, will provide a
logical starting point from which further
chemical mixture studies can be designed
and carried out in rodents. A second major
initiative will be to evaluate persistent
chemicals found in the population for com-
mon biologic activities. For example, many
chemicals with rather diverse structures
have the capacity to interact with the estro-
gen receptor. An assessment in an estro-
genic activity screen (7) of the chemicals
routinely found in the human population
will allow a determination ofwhether envi-
ronmental estrogen exposures are reaching a
level ofconcern in relation to the endoge-
nous levels ofthese hormones. This infor-
mation will also allowfor studies ofrelevant
combinations ofenvironmental estrogens
for possible synergistic activities, as was
recently reported byArnold et al. (8).
One ofmany technical problems that
hinders research into chemical mixtures is
the difficulty in sorting out variations in
responses among animals in basic toxicity
screening assays. Although capable of
detecting a broad array of toxicologic
responses, these assays are perhaps less
useful for studying chemical interactions
than are those with more biologically dis-
crete end points. An example of a useful
new method that is appropriate for chemi-
cal interaction studies is the tripartite estro-
genicity screen described by Shelby et al.
(7). This assay comprises competitive in
vitro binding with the mouse uterine estro-
gen receptor (presumably both the alpha
and newly discovered beta form of the
receptor), transcriptional activation in
HeLa cells transfected with plasmids con-
taining an estrogen receptor and a response
element, and the in vivo uterotropic assay
in mice. This provides for an assessment of
estrogenic activity at three levels oforgani-
zation and should provide considerable
mechanistic insight into an estrogenic or
antiestrogenic activity. This assay strategy
also allows for a high degree ofquantita-
tion ofthe effects ofchemical interactions
when studying mixed exposures. The
NIEHS gives high priority to studies of
persistent organic and inorganic chemicals
identified in the human population for
their interactive effects in this estrogen
activity screen. There is a need for similar
approaches for the study of many other
hormone-dependent responses. This need
was recently made more immediate by the
provisions ofthe Food Quality Protection
Act of 1996 (9). This act requires the U.S.
EPA to analyze, in combination, chemicals
such as pesticide residues appearing in
food, ifthose chemicals act through similar
mechanisms ofaction.
Another major technical advance that
should provide a stimulus to the evaluation
ofchemical mixtures for their carcinogenic
activity is the recent progress made with
transgenic mouse models. These models,
particularly two under intense study at the
NIEHS, hold promise of providing a
means to screen chemicals and chemical
mixtures for carcinogenic activity using far
fewer animals than the traditional 2-year
bioassay, at a much reduced cost, and in
studies of6-months' duration or less.
At a 1995 U.S. NTP Workshop on
Mechanism-Based Toxicology in Cancer
Risk Assessment: Implications for
Research, Regulation, and Legislation
(10), R. Tennant, NIEHS, presented for
discussion the possibility of using geneti-
cally altered mice in routine chemical
carcinogenicity assessment (11). The p53-
deficient and the Tg.AC transgenic
lines were proposed, and currently remain,
the primary lines being evaluated as
adjuncts to or possible replacements for the
rodent bioassay by the NIEHS and the
U.S. NTP.
The p53-deficient mouse is perhaps
one of the more appropriate models for
potential carcinogen identification from
the viewpoint of a strategy for utilizing
transgenic mice. The concept for the use
of the hemizygous p53-deficient model
for detecting potential carcinogens is that
the loss of one functional allele would
render animals more specifically sensitive
to the effects of genotoxic carcinogens.
The results ofstudies to date are encour-
aging in that it appears that this model is
preferentially responsive to mutagenic
carcinogens, target organs are similar to
those identified in the 2-year bioassays,
and the effects are observed after 26
weeks compared to 104 weeks for the
standard bioassay.
In contrast to the p53-deficient line,
theTg.AC line was created by thegermline
insertion of a mutated v-Ha-ras under the
regulation of a fetal zetaglobin promoter
sequence and manifests a unique pheno-
type ofwound- and chemical-induced skin
papillomagenesis. Studies in the Tg.AC
line suggest that the induction of skin
papillomas in this mouse model could be
used as a reporter phenotype for carcino-
gens with target organs other than skin in
2-year assays, and based on all studies com-
pleted so far, the model is responsive to
genotoxic as well as nongenotoxic trans-
species carcinogens. There is also some pre-
liminary evidence that other target tissue
sites in the Tg.AC line will respond after
topical exposure to carcinogens.
The evaluation of transgenic lines by
the U.S. NTP/NIEHS is a diverse activity
involving a combination ofresearch, stan-
dardized testing, and cooperation and
interaction with many groups outside the
institute. These activities are updated regu-
larly on the U.S. NTP web page (12) and
are beyond the scope ofthis report.
As with the estrogen screen, the end
points evaluated in the transgenic mouse
studies are more discrete or cleaner than
those typically evaluated in 2-year bioas-
says. Although tumors are still the end
point ofinterest, the short duration ofthe
studies and the relatively young age of the
animals at the time ofsacrifice results in a
much lower background of neoplasia or
age-related diseases and allows for a more
precise determination oftreatment-related
effects. This is essential to be able to dis-
criminate between chemical interactions
that manifest as additive or synergistic
using reasonable sample sizes.
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In 1993, McLachlan described a research
strategy termed functional toxicology (13).
The purpose was to screen chemicals for
common biologic activities using cells
transfected with molecular constructs con-
taining specific receptors and reporter genes
for that receptor, similar to one part ofthe
estrogen assay described earlier. Batteries of
these cells could then be used to screen for a
wide variety ofreceptor-mediated responses
to chemicals or chemical mixtures. This
approach has the advantage ofproviding a
screening mechanism for chemicals or mix-
tures with unknown biologic properties,
coupled with the ability to provide quantifi-
able responses. Assays ofthis type are now
commercially available and are being used
at the NIEHS under an agreement with the
Agency for Toxic Substances and Disease
Registry to evaluate a number ofpesticides
suspected ofendocrine-altering activities,
and mixtures ofcommon solvents and met-
als found in groundwater contamination
around Superfund waste sites.
When common biologic end points or
common modes ofaction are identified for
discrete chemicals, an initial step in study-
ing potential chemical interactions is to
standardize the activity of the members of
a class of chemicals relative to the most
potent member of the class. These stan-
dardized responses are termed toxic equiva-
lence factors (TEFs). The approach has
perhaps been best developed for 2,3,7,8-
tetrachlorodibenzo-p-dioxin (2,3,7,8-
TCDD) and other dioxinlike chemicals.
The U.S. NTP has a series of 2-year
rodent cancer studies underway to deter-
mine the extent to which TEFs for dioxin
and dioxinlike chemicals predict their
cancer-causing potential, target organ
specificity, and relative potency. There are
several hundred polyhalogenated aromatic
compounds that share certain biologic
response characteristics with dioxin, or
more specifically, 2,3,7,8-TCDD. These
include certain polychlorinated biphenyls
(PCBs) and polybrominated biphenyls,
polychlorodibenzofurans, and other
polychlorinated dibenzo-p-dioxins. TEFs
have been generated for many of these
chemicals, primarily through short-term
studies of non-cancer end points, compar-
ing their potency to that ofdioxin to pro-
duce a few or many of the pleiotropic
responses to this agent. Although studies to
date have indicated a good correspondence
of TEFs to cancer promotion in initia-
tion-promotion studies, this has never
been adequately tested using the traditional
rodent bioassay.
Studies are examining single or combi-
nations of several representatives of the
major classes of dioxinlike chemicals
found in human adipose tissue. Using the
female Sprague-Dawley rat, which is
the strain and sex most sensitive to the
carcinogenic effects of dioxin and
whose response is used as the basis for
human risk assessments, studies include
2,3',4,4'5-pentachlorobiphenyl (PCB
118), 2,3,4,7,8-pentachlorodibenzofuran,
and 3,3',4,4',5-pentachlorobiphenyl
(PCB 126), as well as 2,3,7,8-TCDD.
Also a noncoplanar, nondioxinlike PCB,
2,2',4,4',5,5'-hexachlorobiphenyl (PCB
153) is being studied singly and in a binary
combination with 2,3,7,8-TCDD to exam-
ine possible synergism or antagonism for
the carcinogenic effect of2,3,7,8-TCDD.
Finally, a combination of all chemicals
other than PCB 153 will be tested as a
representative mixture ofdioxinlike chemi-
cals. Doses were selected using published
information from existing prechronic and
chronic rodent studies and the dose ranges
were constructed to provide a rigorous test
of the relationship between TEFs and
carcinogenic potency. Selected tissue con-
centrations ofthe chemicals are being deter-
mined along with a subset of measures
typically used to determine TEFs at various
points during the studies such as tissue
cytochrome P4501A1 and -1A2 activities,
plasma thyroid hormone levels, etc. A
related set ofstudies will evaluate the same
chemicals and combinations in the Tg.AC
transgenic mouse model. This will provide
a rigorous test of the quantitative tumor
response for papillomagenesis in compari-
son with the tumor response in the 2-year
rodent assayfor this large class ofchemicals.
In other NIEHS studies some drugs and
drug combinations commonly encountered
in acquired immune deficiency syndrome
patients are being evaluated for toxicity. Of
specific interest are the interactions of
zidovudine (AZT) with methadone,
rifampin, or sulfamethoxazole/trimetho-
prim. For this reason, concentration time-
course data ofAZT, AZT metabolites, and
the other drugs are being collected in
plasma, liver, vaginal washes, and urine.
The Laboratory of Computational Biology
and Risk Analysis is applying mathematical
methods to the analysis of the pharma-
cokinetic or pharmacodynamic interac-
tions between AZT and the other drugs.
Physiologically based pharmacokinetic
(PBPK)/pharmacodynamic models are
being developed in association with statis-
tical response surface methodologies for
mixture analyses. PBPK models will be
tested against the appropriate experimen-
tal time course data to identify possible
interaction mechanisms.
In summary, U.S. NTP/NIEHS
initiatives in the study of chemical mix-
tures are focusing on complex, real-world
exposures that occur in occupational set-
tings or that are identified through blood
sampling of the general population. New
toxicologic testing methods are providing
more cost- and resource-effective ways to
study chemical mixtures, and these meth-
ods are capable ofgiving information that
is sufficiently quantitative to allow exami-
nations of additive or synergistic actions
of mixtures influencing specific biologic
activities. Finally, where possible, PBPK
models are being used to help unravel the
complex kinetic and biologic events that
must be sorted out to better understand
relationships among exposure to chemical
mixtures, target organ dosimetry, and
adverse effects.
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